Highlight

BIOANALYSIS 2006, March 31   Aster-Cephac turns into SGS Cephac     The Poitiers-based bioanalysis center was recently acquired by the “Société générale de surveillance” (SGS), a Swiss group with no less than 42000 salaried employees throughout the world. The acquisition will allow Aster-Cephac to pronouncedly further its international development. One of the Europe’s largest bioanalysis centers is to be found near Poitiers, in Saint-Benoît. Observers may tend to forget the fact that Aster-Cephac is on a par with giants in its field such as … Paraxel. “We collaborate with 8 of the 10 biggest pharmaceutical laboratories in the world”, states a pertinent Alain Renoux, the site’s managing director. “That’s what assures our reputation. Cephac works for Europe, as well as the United States and Japan.” Given the way the environment is evolving, a small or medium-sized firm now intervenes far more upstream – in phase II, III and IV studies – than had previously been the case. At Cephac, interaction studies are correspondingly multiplying – and this is just the beginning. Acquired by the SGS at the outset of 2006, the Aster-Cephac group, which includes not only the Poitiers center but also an 82-bed clinical unit in the Parisian region, should now dispose of means commensurate with its ambitions. “It matters to know that SGS has 42000 salaried employees worldwide and that its overall 2004 sales reached the figure of 1.9 billion euros”, adds Alain Renoux. 5 new salespeople Through this acquisition, the world-scale specialist in inspection, quality certification and controls intends to develop a part of its activities, the Life Sciences, which presently represents but 4% of its sales. And so, from hereon in, Cephac shall benefit from markedly increased human resources. “Last year, just one person of ours sought out contracts, whereas today, we have four full-time collaborators for Europe and two in the United States.” Cephac is consequently called upon to become the group cornerstone in terms of bioanalyses; little does it matter, in this respect, that SGS is presently opening up laboratories in Thailand and India. To sum matters up, in the coming years the one hundred employees at the Saint-Benoît site should be provided with plenty of studies to carry out. The Biopole en masse at Eurobio 2008 Read ...   Water information days (September 23 – September 25) Read ...   The rose and its genetic transformation Read ...   Christian Huyghe aims for “excellence” read...   Creating “medical branches” read...   A neuro-cardio-vascular pole is taking root read...   Valagro on the horticulture market read...   ERM, the winning spin-off read...   GMOs under debate in Poitiers read...   Isabelle Cameleyre, new representative read...   Cystic fibrosis: The molecule of hope read...   Irfaq, a manufacturer of innovations read...   CHU: State-of-the-art quality read...   Soil organic matter under examination read...   Parexel: The Cap provides its support read...   Philippe Michonneau: “The Biopole, fertile soil” read...   Painless monitoring of hepatitis read...   The Biopole structured as an association read...   Futuramat steps up the pace read...   Technova, or life in 3D read...   B Braun burnishes its image read...   Proteomics platform: The CHU strides ahead read...   The three missions of the University Botanical Garden read...   Clinsight in the big leagues read...   Natural energies for an autonomous building read...   Aster-Cephac turns into SGS Cephac read...   The previously unseen heart read...   BIOalternatives diversifies its markets read...   Two Poitiers-based projects awarded read...   IUT pores over biofuels read...   Poitiers, the biotechnology capital read...   PAREXEL wagers on the human factor read...   Saunier and associates wish to diversify read...   Biocydex and BioXtract move forward hand in hand read...   The grass of champions read...   Ianesco steadfastly believes in its future read...   A tumorotheque, what is the purpose it serves? read...   TechnAvOx has turned the corner read...   Larime is aiming for 40 beds in Poitiers read...   Poitiers is out to promote its research read...   A true Biopole milestone read...   A regional cancerology pole in the pipeline for 2007 read...   Nobel prize winners in Poitiers read...   A platform offering numerous advantages read...   @rtMolecule fashions in its own way read...   It’s plastic, it’s fantastic read...   The Poitiers hospital (CHU) stakes its claim read...   BIOalternatives exports its know-how read...   The physiological and computer science engineering program turns 30 read...   The Biopole takes center stage at Investiga read...           Legal mentions